View Future GrowthNufarm 과거 순이익 실적과거 기준 점검 0/6Nufarm 의 수입은 연평균 -73.5%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 4%의 비율로 감소했습니다. 매출은 연평균 1.1%의 비율로 감소해 왔습니다.핵심 정보-73.53%순이익 성장률-73.46%주당순이익(EPS) 성장률Chemicals 산업 성장률12.93%매출 성장률-1.08%자기자본이익률-7.61%순이익률-5.32%다음 순이익 업데이트19 Nov 2026최근 과거 실적 업데이트공시 • Mar 28+ 1 more updateNufarm Limited to Report First Half, 2026 Results on May 27, 2026Nufarm Limited announced that they will report first half, 2026 results on May 27, 2026공시 • Apr 29+ 1 more updateNufarm Limited to Report First Half, 2025 Results on May 21, 2025Nufarm Limited announced that they will report first half, 2025 results on May 21, 2025공시 • Mar 06+ 2 more updatesNufarm Limited to Report First Half, 2024 Results on May 16, 2024Nufarm Limited announced that they will report first half, 2024 results on May 16, 2024모든 업데이트 보기Recent updates공시 • Mar 28+ 1 more updateNufarm Limited to Report First Half, 2026 Results on May 27, 2026Nufarm Limited announced that they will report first half, 2026 results on May 27, 2026공시 • Nov 20Nufarm Limited, Annual General Meeting, Feb 04, 2026Nufarm Limited, Annual General Meeting, Feb 04, 2026. Location: hybrid meeting, Australia공시 • May 27Nufarm Reportedly Receives Takeover Interest for NuseedAs of May 23, 2025 Nufarm Limited (ASX:NUF)'s share price was down about 38% over five days with its market value at $1 billion, close to the price at which the company's Seed Technologies unit Nuseed Pty. Ltd. is valued. The Seed Technologies unit is now subject to a UBS-run strategic review, which could lead to a sale, after groups such as BP and the KKR-backed Advanta Enterprises Limited expressed interest. A suitor may determine it is better to buy the entire company that was worth double what it is currently trading at a year ago, potentially attracting private -equity suitors. However, one deterrent could be its debt pile, with net debt at $1.36 billion. If a buyer for its $900 million Seed Technologies business cannot be sought, analysts are not ruling out an equity raising.공시 • Apr 29+ 1 more updateNufarm Limited to Report First Half, 2025 Results on May 21, 2025Nufarm Limited announced that they will report first half, 2025 results on May 21, 2025공시 • Mar 24Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)공시 • Dec 12Nufarm Limited Announces Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary SupplementNutriterra®? Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorizes it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims: Supports heart health and cardiovascular function; Supports normal brain function; Source of docosahexaenoic acid (DHA) for maintaining good health; Source of alpha-linolenic acid (ALA) for maintaining good health; source of an essential fatty acid for the maintenance of good health; Source of omega-3 fatty acids for the maintenance of good health. Human clinical trials confirmed that Nutriterra's long-chain fatty acids are readily incorporated into blood lipids. Results were reviewed and authorized by NNHPD and published in Frontiers in Nutrition in 2022. A 2000 mg/day serving of Nutriterra significantly improved indicators of omega-3 status, including the OmegaScore™? and the Omega-3 Index, both of which are supportive of cardiovascular and brain health. While the health benefits of omega-3 fatty acids are well known, few people consume enough of these essential nutrients. Ms. Boettner attributes this to the sensory experiences and ocean health concerns associated with fish oil. This approval follows the Canadian Food Inspection Agency's 2020 approval of Nutriterra for food and feed applications, allowing for greater formulation flexibility for customers. Omega-3 Canola helps fill the gap between how much long-chain omega-3 is needed to support human health and how little the ocean can sustainably provide. Just one hectare of Nuseed Omega-3 canola produces as much DHA as 10,000 one kg wild caught fish. Nutriterra has a unique fatty acid profile with DHA, EPA, and ALA to support human nutrition. This Health Canada approval follows the US Food and Drug Administration (FDA) granting Nutriterra New Dietary Ingredient status in 2021. Having previously obtained food and feed approvals in Australia and New Zealand, the US, and Canada, the company is progressing with additional regulatory applications in other key markets around the world.공시 • Mar 06+ 2 more updatesNufarm Limited to Report First Half, 2024 Results on May 16, 2024Nufarm Limited announced that they will report first half, 2024 results on May 16, 2024공시 • Nov 22Nufarm Limited, Annual General Meeting, Feb 01, 2024Nufarm Limited, Annual General Meeting, Feb 01, 2024.공시 • Nov 17Nufarm Limited Announces Final Dividend for the Period of Six Months Ended 30 September 2023, Payable on 15 December 2023Nufarm Limited announced final dividend of AUD 0.05000000 per share for the period of six months ended 30 September 2023. Ex Date 22 November 2023, Record Date 23 November 2023 and Payment Date 15 December 2023.공시 • Nov 15Nufarm Limited Announces Director ResignationsNufarm Limited announced the resignation of Gordon Davis and Peter Margin as non-executive directors of the Nufarm board, effective November 15, 2023. This completes a 3-year period of board renewal. Gordon Davis joined the Nufarm board on 31 May 2011 following a distinguished executive career in the agribusiness and industrial sectors including as managing director of AWB and senior executive roles at Orica and Incitec Fertilizers. During his 12 year tenure at Nufarm, Gordon served on numerous board committees, including most recently as chair of the risk and compliance committee and previously as chair of the health, safety and environment committee. Peter Margin joined the Nufarm board on 3 October 2011, bringing a wealth of experience in consumer marketing, manufacturing and operations from his executive roles as managing director at National Foods and Goodman Fielder, in addition to his various non executive roles including at Bega Group, Costa and Asahi Beverages. Peter also served on numerous committees during his tenure, most notably chairing the human resources committee for more than 10 years.공시 • Jun 19Nufarm Limited Announces Board ChangesNufarm Limited announced the appointment of Adrian Percy and Federico Tripodi as independent, non-executive directors of the Nufarm Board. These appointments are the final step in a three-year board renewal process, which will conclude later this year with the previously announced retirements of long serving directors Peter Margin and Gordon Davis. Adrian is currently the inaugural Executive Director of the NC Plant Sciences Initiative at North Carolina State University. He has more than 30 years of experience in the agricultural sector, with previous roles as Chief Technology Officer of UPL Ltd. and Head of Research and Development for the Crop Science Division of Bayer. In the latter role, he was a member of their Executive Committee with responsibility for internal and open innovation activities in the areas of crop protection chemistry and biologicals, as well as seeds and traits. During his 25-year tenure at Bayer, he also held numerous positions in agricultural research and development. Adrian is a Venture Partner at Finistere Ventures LLC, a technology and life sciences venture capital investor. He also serves on the board of directors of BioLumic, AgPlenus, FA Bio and Evogene. Adrian holds a BSc from University of Liverpool, an MSc in Toxicology from University of Birmingham and a PhD in Biochemistry from University of Birmingham. He will take up his appointment to the Nufarm board with effect from 1 July 2023 and will stand for election at Nufarm’s Annual General Meeting (AGM) in February 2024. Federico has close to three-decades of involvement in the agri-food sector with his experience spanning general management, research and development, corporate strategy and the commercialization of novel plant biotechnologies targeted for consumers and farmers. Federico currently serves as Chairman at the Agricultural Utilization Research Institute (AURI). He is also the Founder and CEO of Blacktop Holdings, a boutique venture lab that offers strategic and operating partnership services to rapidly growing Ag Tech, Food and Agribusiness companies, their investors and research institutions. From 2016 to 2018, Federico served as the CEO of Calyxt Inc. Prior to Calyxt, Federico worked at Monsanto Company for nearly two decades where his primary focus was developing health, sustainability and renewable energy crop products in the United States and Latin America. Federico holds an MBA from Washington University’s Olin Business School, as well as an agronomic engineering degree from Buenos Aires University. He will take up his appointment to the Nufarm board with effect from today’s date and will stand for election at Nufarm’s AGM in February 2024.공시 • May 18Nufarm Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on June 9, 2023Nufarm Limited announced distribution of AUD 0.05000000 per share for the six months ended March 31, 2023. Record date is May 26, 2023. Ex-date is May 25, 2023. Payment date is June 9, 2023.공시 • Nov 18Nufarm Limited, Annual General Meeting, Feb 02, 2023Nufarm Limited, Annual General Meeting, Feb 02, 2023.매출 및 비용 세부 내역Nufarm가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:NUFM.F 매출, 비용 및 순이익 (AUD Millions)날짜매출순이익일반관리비연구개발비31 Mar 263,347-1788255931 Dec 253,395-1828245930 Sep 253,443-1878225930 Jun 253,421-1177986031 Mar 253,399-467736131 Dec 243,372-367575530 Sep 243,346-267425030 Jun 243,315-167414831 Mar 243,284-57404631 Dec 233,382477374530 Sep 233,4811007334530 Jun 233,5211257215031 Mar 233,5621497095531 Dec 223,6671257155330 Sep 223,7731007225130 Jun 223,752987164331 Mar 223,732957103431 Dec 213,474766793530 Sep 213,216586483730 Sep 201,604-5577253731 Jul 202,847-3768822330 Apr 202,699-2547783131 Jan 202,551-1316683931 Oct 192,612-776433731 Jul 192,674-226183530 Apr 192,772-576343331 Jan 192,871-916503131 Oct 183,090-596583531 Jul 183,308-266673930 Apr 183,260356413831 Jan 183,211966153831 Oct 173,161996003931 Jul 173,1111035854030 Apr 173,0371155704131 Jan 172,9641275554131 Oct 162,877725354031 Jul 162,791165153930 Apr 162,766-335173731 Jan 162,741-835203531 Oct 152,739-265143431 Jul 152,7373150833양질의 수익: NUFM.F 은(는) 현재 수익성이 없습니다.이익 마진 증가: NUFM.F는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: NUFM.F은 수익성이 없으며 지난 5년 동안 손실이 연평균 73.5% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 NUFM.F의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: NUFM.F은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(0.1%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: NUFM.F는 현재 수익성이 없으므로 자본 수익률이 음수(-7.61%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/21 10:44종가2026/06/18 00:00수익2026/03/31연간 수익2025/09/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nufarm Limited는 21명의 분석가가 다루고 있습니다. 이 중 8명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Stephen WilderAlliance Global PartnersJonathan SnapeBell PotterMiriam PritchardBofA Global Research18명의 분석가 더 보기
공시 • Mar 28+ 1 more updateNufarm Limited to Report First Half, 2026 Results on May 27, 2026Nufarm Limited announced that they will report first half, 2026 results on May 27, 2026
공시 • Apr 29+ 1 more updateNufarm Limited to Report First Half, 2025 Results on May 21, 2025Nufarm Limited announced that they will report first half, 2025 results on May 21, 2025
공시 • Mar 06+ 2 more updatesNufarm Limited to Report First Half, 2024 Results on May 16, 2024Nufarm Limited announced that they will report first half, 2024 results on May 16, 2024
공시 • Mar 28+ 1 more updateNufarm Limited to Report First Half, 2026 Results on May 27, 2026Nufarm Limited announced that they will report first half, 2026 results on May 27, 2026
공시 • Nov 20Nufarm Limited, Annual General Meeting, Feb 04, 2026Nufarm Limited, Annual General Meeting, Feb 04, 2026. Location: hybrid meeting, Australia
공시 • May 27Nufarm Reportedly Receives Takeover Interest for NuseedAs of May 23, 2025 Nufarm Limited (ASX:NUF)'s share price was down about 38% over five days with its market value at $1 billion, close to the price at which the company's Seed Technologies unit Nuseed Pty. Ltd. is valued. The Seed Technologies unit is now subject to a UBS-run strategic review, which could lead to a sale, after groups such as BP and the KKR-backed Advanta Enterprises Limited expressed interest. A suitor may determine it is better to buy the entire company that was worth double what it is currently trading at a year ago, potentially attracting private -equity suitors. However, one deterrent could be its debt pile, with net debt at $1.36 billion. If a buyer for its $900 million Seed Technologies business cannot be sought, analysts are not ruling out an equity raising.
공시 • Apr 29+ 1 more updateNufarm Limited to Report First Half, 2025 Results on May 21, 2025Nufarm Limited announced that they will report first half, 2025 results on May 21, 2025
공시 • Mar 24Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)
공시 • Dec 12Nufarm Limited Announces Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary SupplementNutriterra®? Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorizes it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims: Supports heart health and cardiovascular function; Supports normal brain function; Source of docosahexaenoic acid (DHA) for maintaining good health; Source of alpha-linolenic acid (ALA) for maintaining good health; source of an essential fatty acid for the maintenance of good health; Source of omega-3 fatty acids for the maintenance of good health. Human clinical trials confirmed that Nutriterra's long-chain fatty acids are readily incorporated into blood lipids. Results were reviewed and authorized by NNHPD and published in Frontiers in Nutrition in 2022. A 2000 mg/day serving of Nutriterra significantly improved indicators of omega-3 status, including the OmegaScore™? and the Omega-3 Index, both of which are supportive of cardiovascular and brain health. While the health benefits of omega-3 fatty acids are well known, few people consume enough of these essential nutrients. Ms. Boettner attributes this to the sensory experiences and ocean health concerns associated with fish oil. This approval follows the Canadian Food Inspection Agency's 2020 approval of Nutriterra for food and feed applications, allowing for greater formulation flexibility for customers. Omega-3 Canola helps fill the gap between how much long-chain omega-3 is needed to support human health and how little the ocean can sustainably provide. Just one hectare of Nuseed Omega-3 canola produces as much DHA as 10,000 one kg wild caught fish. Nutriterra has a unique fatty acid profile with DHA, EPA, and ALA to support human nutrition. This Health Canada approval follows the US Food and Drug Administration (FDA) granting Nutriterra New Dietary Ingredient status in 2021. Having previously obtained food and feed approvals in Australia and New Zealand, the US, and Canada, the company is progressing with additional regulatory applications in other key markets around the world.
공시 • Mar 06+ 2 more updatesNufarm Limited to Report First Half, 2024 Results on May 16, 2024Nufarm Limited announced that they will report first half, 2024 results on May 16, 2024
공시 • Nov 22Nufarm Limited, Annual General Meeting, Feb 01, 2024Nufarm Limited, Annual General Meeting, Feb 01, 2024.
공시 • Nov 17Nufarm Limited Announces Final Dividend for the Period of Six Months Ended 30 September 2023, Payable on 15 December 2023Nufarm Limited announced final dividend of AUD 0.05000000 per share for the period of six months ended 30 September 2023. Ex Date 22 November 2023, Record Date 23 November 2023 and Payment Date 15 December 2023.
공시 • Nov 15Nufarm Limited Announces Director ResignationsNufarm Limited announced the resignation of Gordon Davis and Peter Margin as non-executive directors of the Nufarm board, effective November 15, 2023. This completes a 3-year period of board renewal. Gordon Davis joined the Nufarm board on 31 May 2011 following a distinguished executive career in the agribusiness and industrial sectors including as managing director of AWB and senior executive roles at Orica and Incitec Fertilizers. During his 12 year tenure at Nufarm, Gordon served on numerous board committees, including most recently as chair of the risk and compliance committee and previously as chair of the health, safety and environment committee. Peter Margin joined the Nufarm board on 3 October 2011, bringing a wealth of experience in consumer marketing, manufacturing and operations from his executive roles as managing director at National Foods and Goodman Fielder, in addition to his various non executive roles including at Bega Group, Costa and Asahi Beverages. Peter also served on numerous committees during his tenure, most notably chairing the human resources committee for more than 10 years.
공시 • Jun 19Nufarm Limited Announces Board ChangesNufarm Limited announced the appointment of Adrian Percy and Federico Tripodi as independent, non-executive directors of the Nufarm Board. These appointments are the final step in a three-year board renewal process, which will conclude later this year with the previously announced retirements of long serving directors Peter Margin and Gordon Davis. Adrian is currently the inaugural Executive Director of the NC Plant Sciences Initiative at North Carolina State University. He has more than 30 years of experience in the agricultural sector, with previous roles as Chief Technology Officer of UPL Ltd. and Head of Research and Development for the Crop Science Division of Bayer. In the latter role, he was a member of their Executive Committee with responsibility for internal and open innovation activities in the areas of crop protection chemistry and biologicals, as well as seeds and traits. During his 25-year tenure at Bayer, he also held numerous positions in agricultural research and development. Adrian is a Venture Partner at Finistere Ventures LLC, a technology and life sciences venture capital investor. He also serves on the board of directors of BioLumic, AgPlenus, FA Bio and Evogene. Adrian holds a BSc from University of Liverpool, an MSc in Toxicology from University of Birmingham and a PhD in Biochemistry from University of Birmingham. He will take up his appointment to the Nufarm board with effect from 1 July 2023 and will stand for election at Nufarm’s Annual General Meeting (AGM) in February 2024. Federico has close to three-decades of involvement in the agri-food sector with his experience spanning general management, research and development, corporate strategy and the commercialization of novel plant biotechnologies targeted for consumers and farmers. Federico currently serves as Chairman at the Agricultural Utilization Research Institute (AURI). He is also the Founder and CEO of Blacktop Holdings, a boutique venture lab that offers strategic and operating partnership services to rapidly growing Ag Tech, Food and Agribusiness companies, their investors and research institutions. From 2016 to 2018, Federico served as the CEO of Calyxt Inc. Prior to Calyxt, Federico worked at Monsanto Company for nearly two decades where his primary focus was developing health, sustainability and renewable energy crop products in the United States and Latin America. Federico holds an MBA from Washington University’s Olin Business School, as well as an agronomic engineering degree from Buenos Aires University. He will take up his appointment to the Nufarm board with effect from today’s date and will stand for election at Nufarm’s AGM in February 2024.
공시 • May 18Nufarm Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on June 9, 2023Nufarm Limited announced distribution of AUD 0.05000000 per share for the six months ended March 31, 2023. Record date is May 26, 2023. Ex-date is May 25, 2023. Payment date is June 9, 2023.
공시 • Nov 18Nufarm Limited, Annual General Meeting, Feb 02, 2023Nufarm Limited, Annual General Meeting, Feb 02, 2023.